Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionation for Prostate Cancer in Africa: A Feasibility Study

NCT06950307 is registered in ClinicalTrials.gov with Muhimbili University of Health and Allied Sciences as lead sponsor.

NCT NCT06950307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06950307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionation for Prostate Cancer in Africa: A Feasibility Study
Lead sponsor
Muhimbili University of Health and Allied Sciences
Phase
Observational
Overall status
Active, not recruiting
Start date
December 30, 2021
Completion date
March 1, 2029
Enrollment
182 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer